Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused

Surgery (United States)

Volumn 158, Issue 3, 2015, Pages 692-699

  Becerra, Adan Z ^a   Probst, Christian P ^a   Tejani, Mohamedtaki A ^a   Aquina, Christopher T ^a   González, Maynor G ^a   Hensley, Bradley J ^a   Noyes, Katia ^a   Monson, John R T ^a   Fleming, Fergal J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURVIVAL; COLON CANCER; CONFERENCE PAPER; DISEASE SEVERITY; FEMALE; HEALTH CARE QUALITY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; UNITED STATES; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; AGED; CANCER STAGING; COLON RESECTION; COLONIC NEOPLASMS; EVALUATION STUDY; FACTUAL DATABASE; MORTALITY; PATHOLOGY; PRACTICE GUIDELINE; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL; TREATMENT OUTCOME; UTILIZATION;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DATABASES, FACTUAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84938953397     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.03.057     Document Type: Conference Paper

References (36)

1. A.B. Benson 3rd, D. Schrag, M.R. Somerfield, and et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 2004 3408 3419
2. P.F. Engstrom, A.B. Benson 3rd, and L. Saltz Colon cancer clinical practice guidelines in oncology J Natl Compr Cancer Netw 1 2003 40 53
3. National Comprehensive Cancer Network. Available at: http://www.nccn.org/professionals/physician-gls/pdf/colon.pdf. Accessed March 16, 2005.
4. C.G. Moertel, T.R. Fleming, J.S. Macdonald, and et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 1990 352 358
5. T. Andre, C. Boni, L. Mounedji-Boudiaf, and et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
6. C.G. Moertel, T.R. Fleming, J.S. Macdonald, and et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report Ann Intern Med 122 1995 321 326
7. T. Spinks, H.W. Albright, T.W. Feeley, and et al. Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America Cancer 118 2012 2571 2582
8. R. Chagpar, Y. Xing, Y.J. Chiang, and et al. Adherence to stage-specific treatment guidelines for patients with colon cancer J Clin Oncol 30 2012 972 979
9. H.B. Muss, and D.L. Bynum Adjuvant chemotherapy in older patients with stage III colon cancer: an underused lifesaving treatment J Clin Oncol 30 2012 2576 2578
10. D. Schrag, L.D. Cramer, P.B. Bach, and C.B. Begg Age and adjuvant chemotherapy use after surgery for stage III colon cancer J Natl Cancer Inst 93 2001 850 857
11. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed May 13, 2015.
12. J.A. Meyerhardt, P.B. Mangu, P.J. Flynn, and et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement J Clin Oncol 31 2013 4465 4470
13. G.M. Boland, G.J. Chang, A.B. Haynes, and et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer Cancer 119 2013 1593 1601
14. N. Wolmark, H.S. Wieand, D.M. Hyams, and et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02 J Natl Cancer Inst 92 2000 388
15. K.Y. Bilimoria, A.K. Stewart, D.P. Winchester, and et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States Ann Surg Oncol 15 2008 683 690
16. D.P. Winchester, A.K. Stewart, J.L. Phillips, and et al. The national cancer data base: past, present, and future Ann Surg Oncol 17 2010 4 7
17. American College of Surgeons. Facility Oncology Registry Data Standards: December 18, 2012. Available at: https://www.facs.org/quality-programs/cancer/ncdb/registrymanuals/cocmanuals/fordsmanual. Accessed May 13, 2015.
18. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
19. C.D. Mack, W. Carpenter, A.M. Meyer, H. Sanoff, and T. Stürmer Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults Cancer 118 2012 2925 2934
20. J.S. Haas, P. Brawarsky, A. Iyer, G.M. Fitzmaurice, B.A. Neville, and C. Earle Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality Cancer 117 2011 4267 4276
21. A.L. Potosky, L.C. Harlan, R.S. Kaplan, and et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer J Clin Oncol 20 2002 1192 1202
22. K.M. Gorey, S. Haji-Jama, E. Bartfay, I.N. Luginaah, F.C. Wright, and S.M. Kanjeekal Lack of access to chemotherapy for colon cancer: multiplicative disadvantage of being extremely poor, inadequately insured and African American BMC Health Serv Res 14 2014 133
23. M.B. Landrum, N.L. Keating, E.B. Lamont, S.R. Bozeman, and B.J. McNeil Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration Cancer 118 2012 3345 3355
24. M. El Shayeb, A. Scarfe, Y. Yasui, and M. Winget Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review BMC Res Notes 5 2012 269
25. T. André, C. Boni, M. Navarro, and et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 2009 3109 3116
26. V.J. Obias, and H.L. Reynolds Multidisciplinary teams in the management of rectal cancer Clin Colon Rectal Surg 20 2007 143 147
27. A.R. Davies, D.A. Deans, I. Penman, and et al. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer Dis Esophagus 19 2006 496 503
28. C. Taylor, A.J. Munro, R. Glynne-Jones, C. Griffiths, P. Trevatt, M.A. Richards, and et al. Multidisciplinary team working in cancer: where are we now? BMJ 340 2010 c951
29. B. Lamb, K. Brown, K. Nagpal, C. Vincent, J.S.A. Green, and N. Sevdalis Team decision making by cancer care multidisciplinary teams: a systematic review Ann Surg Oncol 18 2011 2116 2125
30. E.B. Lindskog, K.Á. Gunnarsdóttir, K. Derwinger, Y. Wettergren, B. Glimelius, and K. Kodeda A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer BMC Cancer 14 2014 948
31. E. MacDermid, G. Hooton, M. MacDonald, G. McKay, D. Grose, N. Mohammed, and et al. Improving patient survival with the colorectal cancer multi-disciplinary team Colorectal Dis 11 2009 291 295
32. K.M. Freund, T.A. Battaglia, E. Calhoun, and et al. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program J Natl Cancer Inst 106 2014 dju115
33. N.Y. Ko, J.S. Darnell, E. Calhoun, and et al. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program J Clin Oncol 32 2014 2758 2764
34. C.A. Vincent Patient safety 2006 Elsevier Churchill Livingstone Edinburgh
35. S. Stump Re-engineering the medication error-reporting process: removing the blame and improving the system Am J Health Syst Pharm 57 Suppl 4 2000 S10 S17
36. P. Bonnabry, C. Despont-Gros, D. Grauser, P. Casez, M. Despond, D. Pugin, and et al. A risk analysis method to evaluate the impact of a computerized provider order entry system on patient safety J Am Med Inform Assoc 15 2008 453 460